Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Leukemia ; 29(7): 1478-84, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25376374

ABSTRACT

Allogeneic stem cell transplantation (SCT) provides the best mechanism of preventing relapse in acute myeloid leukaemia (AML). However non-relapse mortality (NRM) negates this benefit in older patients. Reduced intensity conditioning (RIC) permits SCT with reduced NRM, but its contribution to cure is uncertain. In the MRC AML15 Trial, patients in remission without favourable risk disease could receive SCT from a matched sibling or unrelated donor (MUD). If aged >45 years, a RIC was recommended and in patients aged 35-44 years, either RIC or myeloablative conditioning was permitted. The aim was to determine which approach improved survival and within which prespecified cytogenetic groups. RIC transplants significantly reduced relapse (adjusted hazard ratio (HR) 0.66 (0.50-0.85), P=0.002) compared to chemotherapy The 5-year overall survival from a sibling RIC (61%) was superior to a MUD RIC (37%; adjusted HR 1.50 (1.01-2.21), P=0.04) due to lower NRM (34 vs 14%, P=0.002) In adjusted analyses, there was a survival benefit for sibling RIC over chemotherapy (59 vs 49%, HR 0.75 (0.57-0.97), P=0.03), with consistent results in intermediate and adverse-risk patients. In patients aged 35-44 years, best outcomes were seen with a sibling RIC transplant, although a comparison with chemotherapy and myeloablative transplant was not significant in adjusted analyses (P=0.3).


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Graft vs Host Disease/prevention & control , Hematopoietic Stem Cell Transplantation , Leukemia, Myeloid, Acute/therapy , Transplantation Conditioning , Adult , Allografts , Combined Modality Therapy , Female , Follow-Up Studies , Graft vs Host Disease/mortality , Humans , Leukemia, Myeloid, Acute/mortality , Leukemia, Myeloid, Acute/pathology , Male , Middle Aged , Neoplasm Staging , Prognosis , Siblings , Survival Rate , Transplantation, Homologous , Unrelated Donors
2.
Eur J Cancer ; 49(18): 3856-62, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24011536

ABSTRACT

Diffuse intrinsic pontine glioma (DIPG) has a dismal prognosis with no chemotherapy regimen so far resulting in any significant improvement over standard radiotherapy. In this trial, a prolonged regimen (21/28d) of temozolomide was studied with the aim of overcoming O(6)-methylguanine methyltransferase (MGMT) mediated resistance. Forty-three patients with a defined clinico-radiological diagnosis of DIPG received radiotherapy and concomitant temozolomide (75 mg/m(2)) after which up to 12 courses of 21d of adjuvant temozolomide (75-100mg/m(2)) were given 4 weekly. The trial used a 2-stage design and passed interim analysis. At diagnosis median age was 8 years (2-20 years), 81% had cranial nerve abnormalities, 76% ataxia and 57% long tract signs. Median Karnofsky/Lansky score was 80 (10-100). Patients received a median of three courses of adjuvant temozolomide, five received all 12 courses and seven did not start adjuvant treatment. Three patients were withdrawn from study treatment due to haematological toxicity and 10 had a dose reduction. No other significant toxicity related to temozolomide was noted. Overall survival (OS) (95% confidence interval (CI)) was 56% (40%, 69%) at 9 months, 35% (21%, 49%) at 1 year and 17% (7%, 30%) at 2 years. Median survival was 9.5 months (range 7.5-11.4 months). There were five 2-year survivors with a median age of 13.6 years at diagnosis. This trial demonstrated no survival benefit of the addition of dose dense temozolomide, to standard radiotherapy in children with classical DIPG. However, a subgroup of adolescent DIPG patients did have a prolonged survival, which needs further exploration.


Subject(s)
Brain Stem Neoplasms/therapy , Dacarbazine/analogs & derivatives , Glioma/therapy , Adolescent , Antineoplastic Agents, Alkylating/therapeutic use , Brain Stem Neoplasms/pathology , Chemoradiotherapy , Chemotherapy, Adjuvant , Child , Child, Preschool , Dacarbazine/therapeutic use , Drug Administration Schedule , Female , Glioma/pathology , Humans , Karnofsky Performance Status , Male , Quality of Life , Remission Induction , Survival Analysis , Temozolomide , Time Factors , Treatment Outcome , United Kingdom , Young Adult
3.
BJOG ; 120(11): 1403-12, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23786339

ABSTRACT

OBJECTIVE: Evidence suggests that a high dose of oxytocin for nulliparous women at 37-42 weeks of gestation with confirmed delay in labour increases spontaneous vaginal birth. We undertook a pilot study to test the feasibility of this treatment. DESIGN: Pilot double-blind randomised controlled trial. SETTING: Three teaching hospitals in the UK. POPULATION: A total of 94 consenting nulliparous women at term with confirmed delay in labour were recruited, and 18 were interviewed. METHODS: Women were assigned to either a standard (2 mU/min, increasing every 30 minutes to 32 mU/minute) or a high-dose regimen (4 mU/minute, increasing every 30 minutes to 64 mU/minutes) oxytocin by computer-generated randomisation. Simple descriptive statistics were used, as the sample size was insufficient to evaluate clinical outcomes. The constant comparative method was used to analyse the interviews. MAIN OUTCOMES MEASURES: The main outcome measures: number of women eligible; maternal and neonatal birth; safety; maternal psychological outcomes and experiences; health-related quality of life outcomes using validated tools and data on health service resource use; incidence of suspected delay of labour (cervical dilatation of <2 cm after 4 hours, once labour is established); and incidence of confirmed delay of labour (progress of <1 cm on repeat vaginal examination after a period of 2 hours). RESULTS: We successfully developed systems to recruit eligible women in labour and to collect data. Rates of spontaneous vaginal birth (10/47 versus 12/47, RR 1.2, 95% CI 0.6-2.5) and caesarean section (15/47 versus 17/47, RR 1.1, 95% CI 0.6-2.0) were increased, and rates of instrumental birth were reduced (21/47 versus 17/47, RR 0.8, 95% CI 0.5-1.3). No evidence of increased harm for either mother or baby was found. The incidences of suspected delay (14%) and confirmed delay (11%) in labour were less than anticipated. Of those who did not go on to have delayed labour confirmed, all except one woman gave birth vaginally. CONCLUSIONS: A pilot trial assessing the efficacy of high-dose oxytocin was feasible, but uncertainty remains, highlighting the need for a large definitive trial. The implementation of national guidance of suspected and confirmed delay in labour is likely to reduce intervention.


Subject(s)
Labor Stage, First , Obstetric Labor Complications/drug therapy , Oxytocics/administration & dosage , Oxytocin/administration & dosage , Delivery, Obstetric , Dose-Response Relationship, Drug , Female , Health Knowledge, Attitudes, Practice , Humans , Informed Consent , Interviews as Topic , Parity , Pilot Projects , Pregnancy
4.
Environ Monit Assess ; 13(1): 1-9, 1989 Aug.
Article in English | MEDLINE | ID: mdl-24243106

ABSTRACT

Fixed station sampling is the conventional method used to obtain data on the median water quality of reservoirs. A major source of uncertainty associated with this technique is that water quality at the fixed stations may not be representative of the ambient water quality in the reservoir at the time of sampling. This problem is particularly relevant for water quality variables such as chlorophyll, which have a markedly patchy spatial distribution. The use of Landsat reflectance data to estimate median chlorophyll concentrations in Roodeplaat Dam was investigated. A linear polynomial regression model for estimating chlorophyll concentrations from Landsat reflectance data, was firstly calibrated with chlorophyll concentration data obtained by sampling seven fixed stations on the reservoir at the time of the satellite overflight to produce an individual calibration. Secondly, the model was calibrated with a pooled set of sampled data obtained from five separate overflights, to obtain a generalised calibration.It was found that median chlorophyll concentrations determined from Landsat-derived data were similar to median chlorophyll concentrations estimated from fixed station data. However, the range of chlorophyll concentrations in the reservoir estimated from Landsat data was considerably larger than that estimated from fixed station data. Landsat derived estimates of chlorophyll concentrations have the added advantage of providing information on the spatial distribution of chlorophyll in the reservoir.

SELECTION OF CITATIONS
SEARCH DETAIL
...